Although the downstream effectors of NSD2, such as RUNX2 and p300, which are known to play a role in bone development [130], have been identified, the mechanism by which NSD2 deficiency causes neurological disorders in patients with WHS is still unknown. The gene discussed is NSD2; the disease is nervous system disorder.